Source: http://www.google.com/patents/US20040172083?dq=6,209,672
Timestamp: 2016-07-28 20:43:38
Document Index: 542700287

Matched Legal Cases: ['art 18', 'art 18', 'art 18', 'art 18', 'art 18', 'art 18']

Patent US20040172083 - Acoustically powered implantable stimulating device - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inPatentsAn implantable stimulation system comprises an implantable stimulator and a control device. The control device is configured to transmit acoustic waves to the implantable stimulator, and the implantable stimulator is configured to transform the acoustic waves into electrical current, and generate stimulation...http://www.google.com/patents/US20040172083?utm_source=gb-gplus-sharePatent US20040172083 - Acoustically powered implantable stimulating deviceAdvanced Patent SearchPublication numberUS20040172083 A1Publication typeApplicationApplication numberUS 10/632,265Publication dateSep 2, 2004Filing dateJul 31, 2003Priority dateOct 16, 2000Also published asEP1648559A1, EP1648559B1, US7283874, US7930031, US8577460, US8934972, US20080108915, US20110160804, US20130218251, US20130226259, US20130238044, WO2005009535A1Publication number10632265, 632265, US 2004/0172083 A1, US 2004/172083 A1, US 20040172083 A1, US 20040172083A1, US 2004172083 A1, US 2004172083A1, US-A1-20040172083, US-A1-2004172083, US2004/0172083A1, US2004/172083A1, US20040172083 A1, US20040172083A1, US2004172083 A1, US2004172083A1InventorsAvi PennerOriginal AssigneeRemon Medical Technologies Ltd.Export CitationBiBTeX, EndNote, RefManPatent Citations (14), Referenced by (190), Classifications (19), Legal Events (3) External Links: USPTO, USPTO Assignment, EspacenetAcoustically powered implantable stimulating device
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS [0035] Referring to FIG. 1, an acoustic stimulating system 10 constructed in accordance with one preferred embodiment of the present invention is described. The stimulating system 10 generally comprises a plurality of implantable stimulators 12, which in this embodiment, take the form of pacemakers implanted within the heart 18 of a patient 16. The implantable stimulators 12 are implanted within the heart 18 using minimally invasive means, e.g., a catheter. The stimulating system 10 further comprises a control device 14 configured for being placed on the skin of the patient 16 in order to acoustically transmit acoustic waves 20 through the tissue of the patient 16 to the implantable stimulators 12. In the illustrated embodiment, the acoustic waves 20 can either be acoustic energizing waves or acoustic communication waves, as will be discussed in further detail below. Although, in the illustrated embodiment, the control device 14 is disclosed as an external device, an implantable control device can also be used to transmit acoustic waves 20 to the implantable stimulators 12, as will be described in further detail below. [0036] The acoustic waves 20 transmitted by the control device 14 have a low frequency (e.g., 40 KHz). As such, the implantable stimulators 12 can be implanted within the deep tissue (such as the heart in this case) of the patient 16 without the need to route and implant leads within the body, thereby avoiding, or at least minimizing, the previously described complications. That is, all of the components necessary to stimulate tissue over the lifetime of the implantable stimulators 12 are contained within the implantable stimulators 12. [0037] The control device 14 is configured to energize the implantable stimulators 12, so that the implantable stimulators 12 may subsequently or immediately output stimulation energy into the heart tissue. Besides energizing the implantable stimulators 12, the control device 14 is also configured to control the operation and configuration of the implantable stimulators 12. For example, the control device 14 may activate and deactivate implantable stimulators 12 (i.e., alternately placing them in an “active mode” and “dormant mode”). The control device 14 may also control the parameters of the stimulation energy (e.g., stimulation intensity, pulse duration, and frequency) output from any of the implantable stimulators 12. Significantly, many cardiac applications require that different regions of the heart be stimulated in a particular sequence and delay between stimulations. For example, the two ventricles of the heart may need to be synchronized to optimize the heart pumping capability. As such, the control device 14 may also control the stimulation sequence and timing of the implantable stimulators 12 to achieve this goal. [0038] The control device 14 can selectively communicate with the implantable stimulators 12 by assigning a unique identification code to each implantable stimulator 12. Thus, the control device 14 can selectively energize or communicate with a specific implantable stimulator 12 by incorporating a corresponding unique identification code into the signal transmitted from the control device 14, or alternatively, by transmitting a predetermined pulse sequence representing the identification code prior to energizing or communicating with the specified implantable stimulator 12. By the same token, a specific implantable stimulator 12 can identify itself to the control device 14 by incorporating its unique identification code into the signal transmitting from the control device 14 or by transmitting a pulse sequence representing the unique identification code. [0039] The stimulating system 10 can be designed in a number of manners. For example, in the preferred embodiment, the control device 14 transmits acoustic energizing waves to an implantable stimulator 14, which transforms the acoustic waves into electrical current that are then stored as electrical energy. The implantable stimulator 12 is designed with control logic, in which case, the control device 14 need only transmit stimulation parameters in the form of acoustic communication waves to program the control logic within the implantable stimulator 12, or alternatively, the implantable stimulator 12 can be preprogrammed with the stimulation parameters. The control logic will then control the stimulation energy output from the implantable stimulator 12 in accordance with these programmed stimulation parameters. For example, the control logic can, itself, generate and output the stimulation energy, or the control logic can alternately open and close a switch that selectively outputs the stored electrical energy as stimulation energy. [0040] As another example, the control device 14 may transmit acoustic energizing waves to the implantable stimulator 12, which are then transformed into electrical energy that is immediately used to generate the stimulation energy. In this case, the control logic transforms the electrical energy into stimulation energy in accordance with stimulation parameters stored in the implantable stimulator 12. As still another example, the control device 14 may transmit acoustic energizing waves in accordance with stimulation parameters stored in the control device 14, in which case, the resulting electrical current in the implantable stimulator 12 are immediately output from the implantable stimulator 12 as stimulation energy. In the later case, the electrical current may be further processed in order to generate stimulation energy that is suitable for the intended therapy. The key here is that no energy storage device is required, since the stimulation energy is immediately output in response to the electrical current. [0041] As still another example, the control device 14 may transmit a series of acoustic communication waves in accordance with stimulation parameters stored in the control device 14. The implantable stimulator 12 transforms the acoustic waves into electrical current that alternately open and close a switch that generates the stimulation energy. [0042] Although the implantable stimulators 12 have been described as pacemakers, it should be appreciated that the implantable stimulators 12 may take the form of any device used to therapeutically stimulate body tissue using electrical energy, e.g., an implantable cardioverter defibrillator (ICD), deep brain stimulator (DBS), pain relief nerve stimulator, vagus nerve stimulator, or bladder control stimulator. It should also be appreciated that, although four implantable stimulators 12 are shown, any suitable number of implantable stimulators 12 can be used, including a single implantable stimulator 12. [0043] Referring to FIGS. 2 and 3, the implantable stimulator 10 will now be described in greater detail. The implantable stimulator 10 generally includes a casing 22 that is composed of a biocompatible material, e.g., titanium, gold, platinum, tantalum, stainless steel, or other metal. Alternatively, other biocompatible materials may be used, e.g., a polymer, such as a fluorocarbon, polyamide, or poly ether ether ketone (PEEK), preferably covered with a metallization layer to improve the polymer's performance and/or to enhance its moisture resistance. The casing 22 is shaped such that the implantable stimulator 10 can be embedded within the tissue to be stimulated. In the illustrated embodiment, the casing 22 is bullet-shaped, i.e., it has a flat end 24 that tapers down to a pointed region 26, which can penetrate into tissue. In order to secure and stabilize the implantable stimulator 10 within the tissue, several fixation hooks 28 are mounted to the exterior of the casing 22 near the pointed region 26. [0044] The casing 22 is substantially sealed, and preferably hermetically sealed, to isolate the components of the implantable stimulator 12 from the environment in which the implantable stimulator 10 is to be placed. The casing 22 may include one or more regions that facilitate the passage of acoustic energy through the casing 22. For example, an acoustically transparent panel 30 is suitably mounted over the exposed flat side 24 of the casing 22. Preferably, the panel 30 is a relatively thin wall of titanium or other material, e.g., having a thickness of about one half millimeter (0.5 mm) or less, that may allow the acoustic waves 20 to pass substantially therethrough. [0045] The implantable stimulator 10 further includes an acoustic transducer array 32, a stimulation electrode 34, a reference electrode 36, and a power/communication unit 38. The stimulation electrode 34 is mounted on the pointed region 26 of the casing 22, and the reference electrode 36 is mounted on the flat side 24 of the casing 22. The stimulation electrode 34 is used to electrically stimulate adjacent tissue, and the reference electrode 36 is used as a reference. In the illustrated embodiment, the transducer array 32 comprises four acoustic transducer cells 40 (shown in phantom in FIG. 3). It should be appreciated, however, that the number of transducer cells 40 will ultimately depend on the amount of power needed to energize the implantable stimulator 10, as will be described in further detail below. [0046] The power/communication unit 38 is coupled to the acoustic transducer array 32 and reference electrode 36 via lead 42 and coupled to the stimulation electrode 34 via lead 44 (shown partially in phantom). The power/communication unit 38 is configured for providing electrical stimulation energy to the stimulation electrode 34 in accordance with stimulation parameters stored within the implantable stimulator 12. [0047] The implantable stimulator 12 may optionally include additional secondary stimulation electrodes (not shown), which may be coupled to the power/communication unit 38 via either separate leads, so that the power/communication unit 38 can independently transmit stimulation energy to the electrodes, or using lead 44, so that the power/communication unit 38 can transmit stimulation energy to the electrodes as a group. The implantable stimulator 12 may optionally include one or more sensors (not shown) capable of measuring physiological parameters, such as temperature, electrical impedance, pressure, position, strain, pH, fluid flow, and the like. As will be described in further detail below, this diagnostic information can be used to control the transmission of stimulation energy. Further details regarding the use of sensors and corresponding componentry is disclosed in U.S. patent application Ser. No. 09/989,912, which is expressly incorporated herein by reference. [0048] Referring still to FIG. 2, the acoustic transducer array 32 comprises a substrate 46, four cavities 48 formed completely or partially through the substrate 46, and a flexible piezoelectric layer 50 disposed over the substrate 46 across the cavities 48. The four cavities 48 are filled with a gas, such as air, and thus, the piezoelectric layer 50 will vibrate over the cavities 48, preferably at a frequency equal to the natural frequency of the piezoelectric layer 50. In the illustrated embodiment, each cavity 48 is circular, but can also have other shapes, such as elliptical or rectangular. [0049] The previously described reference electrode 36 is mounted to the outer surface of the piezoelectric layer 50 between the cavities 48. Thus, it can be appreciated that the reference transducer 36 serves as both a common electrode that couples the transducer cells 40 together to provide energizing electrical energy, and a reference point during electrical stimulation of the stimulation electrode 34. Alternatively, a separate common electrode or multiple electrodes (one for each transducer cell 40) can be used to provide the energizing electrical energy to the power/communication unit 38. The acoustic transducer array 32 further comprises four counter electrodes 52 (only two shown in FIG. 2) that are mounted to the inner surface of the piezoelectric layer 50 within the respective cavities 48. In the illustrated embodiment, the transducer cells 40 are connected in parallel by the common electrode 36 in order to increase the generated current. Alternatively, the transducer cells 40 can be connected in series in order to increase the generated voltage. [0050] Thus, it can be appreciated that acoustic waves transmitted to the acoustic transducer array 32 from an external source will cause the piezoelectric layer 50 to vibrate above the cavities 48. As a result, the periodic mechanical strain exerted on the piezoelectric layer 50 generates electrical current at the common electrode 36. Similarly, as electrical current are transmitted to the acoustic transducer array 32 from the power/communication unit 38, an electrical charge will be induced in the piezoelectric layer 50, thereby causing the piezoelectric layer 50 above the cavities 48 to periodically vibrate, resulting in the transmission of acoustic waves. [0051] As best illustrated in FIG. 2, a plurality of depressions are formed in the piezoelectric layer 50, thereby enhancing the efficiency and/or sensitivity of the acoustic transducer array 32. The depressions may also be used to tune the natural resonant frequency of the piezoelectric layer 50. The depressions can be formed by providing the cavities 48 with an internal pressure that is less than the atmospheric pressure, such that the piezoelectric layer 50 partially enters the cavities 48. [0052] In the illustrated embodiment, the diameter of each cavity 48 is approximately 1.2 mm, which results in a maximum acoustic to electrical energy exchange at a frequency of about 40 KHz—translating to a wavelength of 4 cm in water. Since each transducer cell 40 is much smaller than this wavelength, the performance of the implantable stimulator 12 is not affected by the orientation of the transducer array 32 with respect to the acoustic waves 20 transmitted by the control device 14. Further details regarding the structure and manufacture of acoustic transducer arrays are described in U.S. Pat. No. 6,140,740, which is expressly incorporated herein by reference. [0053] Referring now to FIG. 4, the power/communication unit 38 comprises a rectifier 54 and an energy storage device 56. The rectifier 54 is coupled to the transducer array 32 for converting the electrical current generated by the transducer array 32 into a form suitable for powering components of the implantable stimulator 12. Specifically, the rectifier 54 is configured for converting incoming alternating current (AC) voltage from the transducer array 32 into direct current (DC) voltage for storage by the energy storage device 56. The rectification may be performed by diodes arranged in a configuration suitable for the requirements of the mode of operation, preferably resulting in a passive circuit that draws substantially no current. For example, a half-bridge and full-bridge configuration can be used. Alternatively, other rectification circuits (not shown) may be used, including Schottky diodes, voltage triplers or other multiplier circuits, and the like. In addition, the rectifier 54 may include an overvoltage protector (not shown), which may prevent the energy storage device 56 from overcharging to unsafe levels. For example, the overvoltage protector may include a Zener diode, or a transistor that opens at a predetermined threshold voltage. [0054] The energy storage device 56 is capable of being charged from an external source (such as the control device 14) using acoustic energy received by the acoustic transducer array 32. The energy storage device 56 may include any of a variety of devices, such as an energy exchanger, a battery, and/or a capacitor. Preferably, the energy storage device 56 is a battery capable of storing electrical energy substantially indefinitely unless actively discharged. In another embodiment, the energy storage device 56 may include both a capacitor and a primary, non-rechargeable battery, although, alternatively, the energy storage device 56 may include a secondary, rechargeable battery and/or capacitor that may be energized before activation or use of the implantable stimulator 12. For example, the energy storage device 56 may include a Lithium thin film battery, such as those available from Oak Ridge Micro-energy Inc. of Salt Lake City, Utah, Infinite Power Supply of Denver, Colo., or Cymber Corporation of Elk River, Minn. Alternatively, the energy storage device 56 may include a standard coin type manganese lithium rechargeable battery, such as those available from Matsushita Battery Industrial Co., Ltd. (MBI) of Osaka, Japan. [0055] The power/communication unit 38 further comprises a controller 58 coupled between the electrodes 34 and 36 for providing electrical stimulation energy to the electrode 34. The controller 58 may include one or more controllers for controlling components of the implantable stimulator 12, timer circuitry (e.g., a clock or counter), reset and threshold circuitry, and/or a processor for generating electrical signals being transmitted by and/or analyzing electrical signals received by the transducer array 32. The controller 58 can be configured using digital signal processors (DSPs), Field Programmable Gate Arrays (FPGAs), Application Specific Integrated Circuit (ASIC)-compatible microprocessors, such as a CoolRISC processor available from Xemics, or other programmable devices, and/or any other hardware components or software modules that may be required for processing, analyzing, storing data, and controlling operation of the implantable stimulator 12. [0056] The power/communication unit 38 further comprises signal detect circuitry 60 coupled to the transducer array 32 for providing a communication channel into the implantable stimulator 12, and specifically, to pass commands and/or information in the acoustic communication waves received by the transducer array 32 for use by the controller 58. For example, the signal detect circuitry 60 may pass commands or other signals to the controller 58, e.g., that acoustic energizing waves have been discontinued, that the implantable stimulator 12 should become operative and/or stimulation parameters. The signal detect circuitry 60 may be a passive FET circuit, thereby drawing substantially no current. The signal detect circuitry 60 may also include a smoothing capacitor (not shown) and/or logic for reducing the sensitivity of the signal detect circuitry 60 to spurious transient signals. [0057] The power/communication unit 38 comprises optional transmission circuitry 62 coupled to the transducer array 32 for providing a communication channel from the implantable stimulator 12, e.g., to pass status information or optional sensor data to the control device 14 as acoustic communication waves. The signals are preferably digital electrical signals, which may be generated, for example, by grounding the counter electrodes 52 (shown in FIG. 2) of the transducer array 32 and alternately connecting the common electrode 36 (shown in FIG. 2) between ground and a predetermined voltage. Alternatively, the signals may be generated by alternately grounding the common electrode 36 and connecting the counter electrodes 52 to the predetermined voltage, and then grounding the counter electrodes 52 and connecting the common electrode 36 to the predetermined voltage. In a further alternative, the signal may be processed or modulated, e.g., using spread spectrum, direct sequence mixing, code division multiple access (CDMA), or other technologies, as will be appreciated by those skilled in the art. [0058] The power/communication unit 38 comprises memory 64, e.g., volatile or non-volatile memory, including flash memory or ferroelectric memory. The memory 64 may store information, e.g., data received from the optional sensors of the implantable stimulator 12, commands and stimulation parameters for use by the controller 58 to provide stimulation energy to the electrode 34. [0059] The power/communication unit 38 comprises a switch 66 coupled between the energy storage device 56 and the controller 58, such that all or part of the controller 58 may be selectively activated and deactivated under control of the control device 14. Optionally, use of the switch 66 may be foregone, in which case, the controller 58 can be directly connected to the energy storage device 56, such that at least some component(s) of the controller 58 may remain active at all times. [0060] The switch 66 can be operated to alternately place the implantable stimulator 12 in an “active mode” or a “dormant mode.” Specifically, to place the implantable stimulator 12 in the active mode, the switch 66 may be closed upon acoustic excitation by an external acoustic energy source, e.g., from the control device 14, to allow current flow from the energy storage device 56 to the controller 58, thereby activating the implantable stimulator 12. To place the implantable stimulator 12 in a “dormant mode,” the switch 66 can may be opened upon acoustic excitation by the control device 14, to prevent current from flowing from the energy storage device 56 to the controller 58. Basically, an acoustic transmission from the control device 14 may vibrate the transducer array 32, forming a voltage pulse that is conveyed to the switch 66. When the voltage exceeds a predetermined threshold, e.g., about a half volt (0.5 V), the switch 66 may close if previously in an open state, or open if previously in an a closed state. [0061] Further details regarding the structure and function of the power/communication unit 38 are disclosed in U.S. patent application Ser. No. 09/989,912, which has previously been incorporated herein by reference. [0062] Referring to FIG. 5, an alternative embodiment of a power/communication unit 138 that can be used in the acoustic stimulator 12 is described. The power/communication unit 138 is similar to the power/communication unit 38 described above, with the exception that the controller 58 immediately uses the electrical current to generate the stimulation energy. Specifically, the controller 58 receives the electrical energy directly from the rectifier 54 and generates the stimulation energy in response thereto. Any excess electrical energy not used by the controller 58 to generate the stimulation energy is output to the energy storage device 56 for subsequent use by the controller 58 or other components. [0063] The following description illustrates exemplary energy consumption parameters needed for the power/communication unit 138 to generate the proper amount of stimulation energy, and, consequently, exemplary power requirements for the acoustic transducer array 32. A single acoustic transducer cell 40 will typically generate 15 Pq/KPa at a frequency of approximately 40 KHz and a voltage of 10 V. The theoretical induced current at an acoustic pressure of 50 KPa will be 15 Pq/KPa�50 KPa�40 KHz=30 μA. Assuming a 50% AC to DC rectification efficiency, the practical induced current will be 15 μA. The resulting power will be 15 μA�10 V=0.15 mW. Assuming that twenty acoustic transducer cells 40 are connected in parallel, the total power generated by the transducer array 32 will be 20�0.15 mW=3 mW. A typical pacemaker has the following operational characteristics: amplitude of 2.5 V, frequency of 80 Hz, pulse width of 0.4 msec, and impedance of 1000 ohms. Thus, the power required by the acoustic stimulator 12 will be (2.5 V)2�1/1000 ohms�80 Hz�4�10−4 sec=0.2 mW. As such, the implantable stimulator 12 (assuming 20 transducer cells 40) will generate 15 times the energy required for pacing the heart 18. The excess energy can be used to charge the energy storage device 56 to allow operation of the implantable stimulator 12 without acoustic excitation from the control device 14. [0064] Referring to FIG. 6, another alternative embodiment of a power/communication unit 238 that can be used in the acoustic stimulator 12 will now described. The power/communication unit 238 is similar to the previously described power/communication unit 38, with the exception that the controller 58 does not output the stimulation energy. Rather, the controller 58 alternately opens and closes the switch 66 in order to discharge the energy storage device 56 through the switch 66 to produce the stimulation energy. In this case, the frequency that the switch 66 is opened and closed defines the frequency of the stimulation energy, and the duration that the switch 66 is opened in each cycle defines the pulse width of the stimulation energy. [0065] Referring to FIG. 7, still another alternative embodiment of a power/communication unit 338 that can be used in the acoustic stimulator 12 will now described. The power/communication unit 338 is similar to the previously described power/communication unit 238, with the exception that a controller 58 is not used to alternately open and close the switch 66. Instead, the control device 14 alternately opens and closes the switch 66 by transmitting acoustic communication waves 20 to the implantable stimulator 12. Because output of the stimulation energy is completely controlled by the control device 14, the power/communication unit 338 need not include a controller 58, thereby rendering the implantable stimulator 12 a “dumb device.” Of course, the power/communication unit 338 can alternatively use a controller 58 if control of other functions within the implantable stimulator 12, such as sensing, is needed. [0066] Referring to FIG. 8, yet another alternative embodiment of a power/communication unit 438 that can be used in the acoustic stimulator 12 will now described. Like the power/communication unit 338, the power/communication unit 438 is a “dumb device.” Unlike the power/communication unit 338, the output of the stimulation energy is not controlled by alternately opening and closing a switch 66. Rather, the control device 14 transmits acoustic energizing waves 20 in accordance with stimulation parameters stored in the control device 14. For example, the control device 14 can generate pulsed acoustic energizing waves 20 that is transformed into pulsed electrical energizing waves in the implantable stimulator 12. The power/communication unit 338 comprises a rectifier 54 that then transforms the AC components of the pulsed electrical current into DC components, thereby resulting in a digital electrical signal, which is then output from the implantable stimulator 12 as stimulation energy. [0067] Although the previously described implantable stimulator 12 is self-contained, thereby eliminating the need to implant and route external leads, other types of implantable stimulators can be used in the stimulation system 10 instead of the implantable stimulator 12. For example, FIG. 9 illustrates an alternative embodiment of an implantable stimulator 72 that uses an external lead. Specifically, the implantable stimulator 72 comprises a stimulating electrode 74 and a control unit 76 that are coupled together through an external lead 78. Alternatively, several stimulating electrodes can be provided. For example, the stimulating electrodes may be independent of each other, in which case, the electrodes can be connected to the control unit 76 via parallel external leads. Or the stimulating electrodes may be integrated together on a single unit, in which case, the electrode unit can be connected to the control unit 76 via a single external lead with one or more wires. [0068] The control unit 76 comprises a casing 80 that is similar to the previously described casing 22, with the exception that the casing 80 is cylindrically shaped. The control unit 76 further comprises an acoustic transducer array 82 that is similar to the previously described transducer array 32, with the exception the transducer array 82 is circumferentially distributed around the cylindrical casing 80. The control unit 76 further comprises the previously described power/communication unit 84, which is suitably mounted within the casing 80. Since almost all of the componentry is located within the control unit 76, the stimulation electrode 74 can be made smaller, thereby facilitating delivery and implantation of the stimulation electrode 74 in the target region of the heart 18. The control unit 76 may be implanted in the chest region of the patient 16. [0069] With particular reference to FIGS. 10 and 11, the control device 14 will now be described in detail. The control device 14 comprises a controller 86 for controlling its operation, and an energy storage device 88, e.g., a nonrechargeable or a rechargeable battery, coupled to the controller 86 and/or other components of the control device 14, such as a power amplifier or an oscillator (not shown). In addition, the control device 14 comprises an acoustic transducer 90 configured for converting between electrical current and acoustic waves in a similar manner described above with respect to the transducer array 32. Alternatively, separate and/or multiple acoustic transducers may be provided for transmitting and receiving acoustic waves. [0070] The control device 14 further comprises memory 92 coupled to the controller 86, e.g., for storing commands, stimulation parameters, and/or data provided to the control device 14, as explained further below. The memory 92 may be a temporary buffer that holds data before transfer to another device, or non-volatile memory capable of storing the data substantially indefinitely, e.g., until extracted by the controller 86. For example, the memory 92 may be a memory card or an EPROM (not shown) built into the control device 14 or otherwise coupled to the controller 86. In the preferred embodiment, the implantable stimulator 12 may be operated in a “half-duplex” mode. In this mode, the implantable stimulator 12 can only either transmit or receive during any given time. To this end, the control device 14 comprises a transmitting/receiving (T/R) switch 94, which toggles the transducer 90 to alternately transmit and receive acoustic energy. Lastly, the control device 14 comprises a casing 96 for housing the previously described components. [0071] As best illustrated in FIG. 10, the control device 14 is preferably carried by a patch 15 that may be secured to a patient, e.g., to the patient's skin. For example, the patch 15 may include one or more layers of substantially flexible material to which the control device 14 and/or its individual components are attached. The patch 15 may include a single flexible membrane (not shown) to which the control device 14 is bonded or otherwise attached, e.g., using a substantially permanent adhesive, which may facilitate conformance of the patch 15 to the patient's anatomy. Alternatively, the control device 14 may be secured between layers of material, e.g., within a pouch or other compartment (not shown) within the patch 15. For example, the patch 15 may include a pair of membranes (not shown) defining the pouch or compartment. The space within which the control device 14 is disposed may be filled with material to acoustically couple the acoustic transducer 90 of the control device 14 to an outer surface of the patch 15. Alternatively, the acoustic transducer 90 may be exposed, e.g., in a window formed in a wall of the patch 15. [0072] The patch 15 may be formed from a flexible piezoelectric material, such as Polyvinylidene Fluoride (PVDF) or a PVDF copolymer. Such polymers may allow the patch 15 to produce ultrasonic waves, as well as allowing the control device 14 to be secured to the patient's skin. Thus, the wall of the patch 15 itself may provide an acoustic transducer for the control device 14, i.e., for transmitting acoustic energy to and/or receiving acoustic energy from the implantable stimulator 12. [0073] The patch 15 may then be secured to the patient's skin using a material, such as a layer of adhesive (not shown), substantially permanently affixed or otherwise provided on a surface of the patch 15. The adhesive may be hydrogel, silicon, polyurethane, polyethylene, polypropylene, fluorocarbon polymer, and the like. Alternatively, a separate adhesive may be applied to the patch 15 and/or to the patient's skin before applying the patch 15 in order to secure the control device 14 to the patient's skin. Such an adhesive may enhance acoustic coupling of the acoustic transducer(s) of the control device 14 to the patient's skin, and consequently to the implantable stimulator 12. Optionally, additional wetting material, including water, silicone oil, silicone gel, hydrogel, and the like, and/or other acoustically conductive material may be provided between the patch 15 or the acoustic transducer 90, and the patient's skin, e.g., to provide substantial continuity and minimize reflection or other losses and/or to secure the patch 15 to the patient 16. [0074] The patch 15 may be relatively light and compact, for example, having a maximum surface dimension (e.g., width or height) not more than about ten to two hundred millimeters (10-200 mm), a thickness not more than about five to one hundred millimeters (5100 mm), and a weight not more than about twenty to four hundred grams (20-400 g), such that the control device 14 may be inconspicuously attached to the patient. Thus, the patient 16 may be able to resume normal physical activity, without substantial impairment from the control device 14. Yet, the energy storage device 88 may be sufficiently large to communicate with the implantable stimulator 12 for an extended period of time, e.g., for hours or days, without requiring recharging or continuous coupling to a separate energy source. [0075] Alternatively, the control device 14 may be carried by a belt (not shown) that may be secured around the patient, e.g., such that the acoustic transducer 90 is secured against the patient's skin. The belt may carry other components, e.g., an external power supply for the control device 14. For example, a battery pack (not shown) may be carried by the belt that may be coupled to the control device 14 for providing electrical energy for its operation. Alternatively, the control device 14 may take the form of a probe that is not worn by the patient 16, but rather can be selectively placed on the chest in order to communicate with the implantable stimulator 16. [0076] Alternatively, a control device, similar to the previously described control device 14, may be implanted within the patient 16, e.g., the chest near the heart region. For example, FIG. 12 illustrates an implantable control device 114 that can be used to communicate with an implantable stimulators 16 within the heart 18 of the patient 16. In this case, the implantable control device 114 communicate in the same manner as the control device 14. The main difference is that the implantable control device 114 is preferably capable of being recharged by an external energizing device 116 via RF or acoustic energy. In addition, the implantable control device 114 will typically not have the required stored energy for energizing the implantable stimulators 16. Instead, the implantable stimulators 16 may be energized by the external energizing device 116. In this case, the implantable control device 114 will be used to control the operation of the implantable stimulators 16, e.g., by alternately activating and deactivating selected implantable stimulators 16, or otherwise controlling the stimulation energy output from the implantable stimulators 16. Further details on this particular arrangement are disclosed in U.S. patent application Ser. No. 10/413,428, which is expressly incorporated herein by reference. [0077] When used in conjunction with the implantable stimulator 12 having the power/communication unit 36 or power/communication unit 236 illustrated in respective FIGS. 4 and 6, the control device 14 can be operated in an “energizing mode” or “activation mode.” When operated in either of these modes, the control device 14 transmits acoustic waves 20 from the acoustic transducer 90 through the body of the patient 16, with at least a portion of the acoustic waves 20 striking the transducer array 32 of the implantable stimulator 12. The transducer array 32 converts the acoustic waves into electrical current, which are used to either charge the energy storage device 56 or communicate with the controller 86 in the implantable stimulator 12 depending on the operational mode. [0078] At the beginning of the energizing mode, the control device 14 determines the optimum frequency at which the implantable stimulator 12 should be energized. For example, the control device 14 may transmit a broadband acoustic waves or scanning waves, i.e., scanning through a range of frequencies, and wait for the implantable stimulator 12 to respond. The implantable stimulator 12 may transmit acoustic waves at different frequencies in response to the diagnostic signal, and the control device 14 may determine the optimal frequency for communicating with the implantable stimulator 12 based upon the responses. For example, the control device 14 may repeatedly charge the implantable stimulator 12 using different frequency signals and measure the length of time that the implantable stimulator 12 is capable of transmitting data signals at each frequency to determine the optimal frequency. Alternatively, when the implantable stimulator 12 detects the signal, it may transmit a response at an optimal frequency that should be used to communicate with the implantable stimulator 12. [0079] Once the control device 14 has determined the optimal frequency for communicating with the implantable stimulator 12 (or the control device 14 may already know the proper frequency to use), the control device 14 then transmits acoustic energizing waves 20 to the implantable stimulator 12, which are transformed and stored in the energy storage device 56 as electrical energy. The energy storage device 56 continues to store electrical energy until a predetermined voltage is achieved, e.g., about eight Volts (8 V), and then the controller 58 automatically disconnects the energy storage device 56 from the transducer array 32. After a predetermined time, e.g., between about five and sixty seconds (5-60 sec.), the control device 14 automatically ceases the energizing transmission. Alternatively, the control device 14 may cease energizing the implantable stimulator 12 by transmitting a stop command. [0080] During the activation mode, the control device 14 transmits a command to the implantable stimulator 12 to close the switch 66, thereby placing the implantable stimulator 12 in the active mode. Once activated, the implantable stimulator 12 draws electrical energy from the energy storage device 56, and begins to transmit electrical energy to the stimulation electrode 34 in accordance with stimulation parameters, which may be previously stored in the memory 92 or may be transmitted from the control device 14 immediately after activation of the implantable stimulator 12. Alternatively, if no switch 66 is used, the control device 14 may transmit a start command to the implantable stimulator 12, which responds by transmitting electrical energy to the stimulation electrode 34. [0081] The implantable stimulator 12 continues to stimulate the tissue until the control device 14 transmits a command to the implantable stimulator 12 to open the switch 66, thereby deactivating the implantable stimulator 12 and placing it in the dormant mode. Alternatively, if no switch 66 is used, the control device 14 may transmit a stop command to the implantable stimulator 12, which responds by ceasing transmission of the electrical energy to the stimulation electrode 34. Stimulation may also cease if the voltage of the energy storage device 56 falls below a predetermined threshold, e.g., below a level at which the stimulation electrode 34 may not continue to operate effectively, such as 1.5 volts. After the voltage falls below the predetermined threshold, the controller 58 may automatically discontinue operation of the implantable stimulator 12 by opening the switch 66 and returning to a dormant state until energized and activated by the control device 14. [0082] Prior to, during, or subsequent to the activation mode, the control device 14 and implantable stimulator 12 may communicate additional information to each other. For example, the implantable stimulator 12 may transmit diagnostic information, which has been sensed by the optional sensor (not shown), to the control device 14. The control device 14 can then use this information to control the operation of the implantable stimulator 12. For example, the optional sensor can be a pressure sensor that can sense the blood flow through the heart chamber in which the implantable stimulator 12 is located. In this case, the implantable stimulator 12 can transmit pressure information to the control device 14. Alternatively, the pressure sensor may be even associated with another implantable device that is located in another region of the body, e.g., a pulmonary vein. The control device 14 may then respond to this pressure information by either activating or deactivating the implantable stimulator 12. [0083] For example, if the pressure information indicates that the blood flow is below normal, the control device 14 may activate the implantable stimulator 12 by transmitting commands to close the switch 66, thereby initiating stimulation of the heart tissue. Once the diagnostic information indicates that the blood flow has been normal for a predetermined period of time, the control device 14 can then deactivate the implantable stimulator 12 by transmitting commands to open the switch 66, thereby ceasing stimulation of the heart tissue. This technique lends itself well to implantable cardioverter defibrillators (ICDs), which are designed to shock the heart when the blood pressure within the heart falls to a dangerous level. The control device 14 may alternatively or optionally use the diagnostic information to control the implantable stimulator 12 by controlling the parameters of the stimulation energy output by the implantable stimulator 12. [0084] As another example for communicating information to each other, the control device 14 may transmit an identification code when transmitting commands to open or close the switch 66 in the implantable stimulator 12. In this manner, timing and sequence of the stimulation energy output from all of the implantable stimulators 12 can be controlled. Prior to placing the implantable stimulator 12 in the dormant mode, the controller 58 may transmit status information to the control device 14, e.g., an initial confirmation of instructions received from the control device 14, an identification code identifying the implantable stimulator 12, and/or a stop notice when stimulation is being discontinued by the controller 58. [0085] As a safety measure against false positives (e.g., erroneous activation or deactivation), the control device 14 may acoustically transmit an initiation signal followed by a confirmation signal. When the implantable stimulator 12 receives these signals, the controller 58 may monitor the signals for a proper sequence, thereby ensuring that the switch 66 only closes upon receiving the proper initiation and confirmation signals. For example, the controller 58 may only acknowledge an activation signal that includes a first pulse followed by a second pulse separated by a predetermined delay. Use of a confirmation signal may be particularly important for certain applications, for example, to prevent unintentional stimulation of the heart 18. [0086] In the case where the power/communication unit 138 illustrated in FIG. 5 is used in the implantable stimulator 12, the electrical current transformed by the implantable stimulator 12 is not used to charge the energy storage device 56, but rather to immediately generate stimulation energy. As such, the control device 14 is operated in the energizing mode in order to energize the implantable stimulator 12, resulting in immediate output of the stimulation energy to the tissue. Communication between the implantable stimulator 12 and control device 14 can be accomplished in the same manner previously discussed above. [0087] In the case where the power/communication unit 238 illustrated in FIG. 7 is used in the implantable stimulator 12, the control device 14 can be designed to operate in the previously described “energizing mode” and a “stimulation mode.” In the energizing mode, the control device 14 energizes the implantable stimulator 12 in the same manner described above. In the stimulation mode, the control device 14 transmits acoustic communication waves to the implantable stimulator 12 in order to alternately open and close the switch 66, so that energy storage device 56 is periodically discharged to generate and output the stimulation energy. [0088] In the case where the power/communication unit 338 illustrated in FIG. 8 is used in the implantable stimulator 12, the control device 14 can be designed to operate in the energizing mode. In this case, the control device 14 transmits pulsed acoustic energizing waves in accordance with stimulation parameters stored in the control device 14. The implantable stimulator 12 responds by transforming the AC components of the resulting electrical current into DC components. That is, the pulsed AC electrical current are transformed into pulses DC electrical current, which are then output as the stimulation energy. [0089] Although particular embodiments of the present invention have been shown and described, it should be understood that the above discussion is not intended to limit the present invention to these embodiments. It will be obvious to those skilled in the art that various changes and modifications may be made without departing from the spirit and scope of the present invention. Thus, the present invention is intended to cover alternatives, modifications, and equivalents that may fall within the spirit and scope of the present invention as defined by the claims. Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS4082097 *May 20, 1976Apr 4, 1978Pacesetter Systems Inc.Multimode recharging system for living tissue stimulatorsUS5168869 *Jun 17, 1991Dec 8, 1992Raul ChirifeRate responsive pacemaker controlled by isovolumic contraction timeUS5248083 *Nov 9, 1992Sep 28, 1993Honeywell Inc.Adaptive furnace control using analog temperature sensingUS5315721 *Jan 7, 1993May 31, 1994Okun Milton RCollapsible shower stallUS5712917 *Nov 22, 1994Jan 27, 1998George C. OffuttSystem and method for creating auditory sensationsUS5749909 *Nov 7, 1996May 12, 1998Sulzer Intermedics Inc.Transcutaneous energy coupling using piezoelectric deviceUS5861018 *May 28, 1996Jan 19, 1999Telecom Medical Inc.Ultrasound transdermal communication system and methodUS6185452 *Feb 25, 1998Feb 6, 2001Joseph H. SchulmanBattery-powered patient implantable deviceUS6198965 *May 17, 1999Mar 6, 2001Remon Medical Technologies, Ltd.Acoustic telemetry system and method for monitoring a rejection reaction of a transplanted organUS6198971 *Aug 6, 1999Mar 6, 2001Implex Aktiengesellschaft Hearing TechnologyImplantable system for rehabilitation of a hearing disorderUS6259951 *May 12, 2000Jul 10, 2001Advanced Bionics CorporationImplantable cochlear stimulator system incorporating combination electrode/transducerUS20010031909 *Mar 30, 2001Oct 18, 2001Faltys Michael A.High contact count, sub-miniature, fully implantable cochlear prosthesisUS20020045921 *Jun 21, 2001Apr 18, 2002Remon Medical Technologies Ltd.Implantable pressure sensors and methods for making and using themUS20020077673 *Nov 19, 2001Jun 20, 2002Remon Medical Technologies, Ltd.Systems and methods for communicating with implantable devices* Cited by examinerReferenced byCiting PatentFiling datePublication dateApplicantTitleUS7239920 *Feb 11, 2003Jul 3, 2007Advanced Bionics CorporationNeural stimulation system providing auto adjustment of stimulus output as a function of sensed pressure changesUS7317948Feb 11, 2003Jan 8, 2008Boston Scientific Scimed, Inc.Neural stimulation system providing auto adjustment of stimulus output as a function of sensed impedanceUS7471986Feb 20, 2004Dec 30, 2008Cardiac Pacemakers, Inc.System and method for transmitting energy to and establishing a communications network with one or more implanted devicesUS7489967 *Jul 9, 2004Feb 10, 2009Cardiac Pacemakers, Inc.Method and apparatus of acoustic communication for implantable medical deviceUS7558631Sep 27, 2006Jul 7, 2009Ebr Systems, Inc.Leadless tissue stimulation systems and methodsUS7570998 *Jul 20, 2007Aug 4, 2009Cardiac Pacemakers, Inc.Acoustic communication transducer in implantable medical device headerUS7606621Oct 20, 2009Ebr Systems, Inc.Implantable transducer devicesUS7610092 *Oct 27, 2009Ebr Systems, Inc.Leadless tissue stimulation systems and methodsUS7613511 *Nov 3, 2009Cardiac Pacemakers, Inc.Implantable vagal stimulator for treating cardiac ischemiaUS7615012 *Aug 26, 2005Nov 10, 2009Cardiac Pacemakers, Inc.Broadband acoustic sensor for an implantable medical deviceUS7647109Jan 12, 2010Boston Scientific Scimed, Inc.Leadless cardiac stimulation systemsUS7650186Jan 19, 2010Boston Scientific Scimed, Inc.Leadless cardiac stimulation systemsUS7684869Jan 30, 2006Mar 23, 2010Boston Scientific Neuromodulation CorporationApparatus and method for determining the relative position and orientation of neurostimulation leadsUS7702392Feb 10, 2006Apr 20, 2010Ebr Systems, Inc.Methods and apparatus for determining cardiac stimulation sites using hemodynamic dataUS7742823May 10, 2007Jun 22, 2010Boston Scientific Neuromodulation CorporationNeural stimulation system providing auto adjustment of stimulus output as a function of sensed impedanceUS7744542Jun 29, 2010Cardiac Pacemakers, Inc.Implanted air passage sensorsUS7751881 *Jul 6, 2010Ebr Systems, Inc.Acoustically-powered wireless defibrillatorUS7756587Jul 13, 2010Cardiac Pacemakers, Inc.Systems and methods for communicating with implantable devicesUS7765001Aug 29, 2006Jul 27, 2010Ebr Systems, Inc.Methods and systems for heart failure prevention and treatments using ultrasound and leadless implantable devicesUS7801621Sep 21, 2010Boston Scientific Neuromodulation CorporationNeural stimulation system providing auto adjustment of stimulus output as a function of sensed pressure changesUS7840281Nov 23, 2010Boston Scientific Scimed, Inc.Delivery of cardiac stimulation devicesUS7848815Sep 4, 2009Dec 7, 2010Ebr Systems, Inc.Implantable transducer devicesUS7848823Dec 7, 2010Boston Scientific Scimed, Inc.Cardiac stimulation systemUS7853330Nov 12, 2007Dec 14, 2010Boston Scientific Neuromodulation CorporationApparatus and method for determining the relative position and orientation of neurostimulation leadsUS7890173Sep 4, 2009Feb 15, 2011Ebr Systems, Inc.Implantable transducer devicesUS7894904 *Jun 18, 2007Feb 22, 2011Ebr Systems, Inc.Systems and methods for implantable leadless brain stimulationUS7894907 *Jun 18, 2007Feb 22, 2011Ebr Systems, Inc.Systems and methods for implantable leadless nerve stimulationUS7894910 *Jun 18, 2007Feb 22, 2011Ebr Systems, Inc.Systems and methods for implantable leadless cochlear stimulationUS7899541 *Mar 1, 2011Ebr Systems, Inc.Systems and methods for implantable leadless gastrointestinal tissue stimulationUS7899542 *Mar 1, 2011Ebr Systems, Inc.Systems and methods for implantable leadless spine stimulationUS7930031Apr 19, 2011Remon Medical Technologies, Ltd.Acoustically powered implantable stimulating deviceUS7937161May 3, 2011Boston Scientific Scimed, Inc.Cardiac stimulation electrodes, delivery devices, and implantation configurationsUS7953493Dec 19, 2008May 31, 2011Ebr Systems, Inc.Optimizing size of implantable medical devices by isolating the power sourceUS7996087 *Aug 9, 2011Ebr Systems, Inc.Leadless tissue stimulation systems and methodsUS8027724 *Aug 3, 2007Sep 27, 2011Cardiac Pacemakers, Inc.Hypertension diagnosis and therapy using pressure sensorUS8050774Nov 1, 2011Boston Scientific Scimed, Inc.Electrode apparatus, systems and methodsUS8078278Mar 10, 2006Dec 13, 2011Remon Medical Technologies Ltd.Body attachable unit in wireless communication with implantable devicesUS8078283 *Jun 18, 2007Dec 13, 2011Ebr Systems, Inc.Systems and methods for implantable leadless bone stimulationUS8082041Dec 20, 2011Piezo Energy Technologies, LLCBio-implantable ultrasound energy capture and storage assembly including transmitter and receiver coolingUS8131357Apr 1, 2005Mar 6, 2012Boston Scientific Neuromodulation CorporationApparatus and methods for detecting migration of neurostimulation leadsUS8147415Mar 30, 2009Apr 3, 2012Cardiac Pacemakers, Inc.System and method for detection of pulmonary embolismUS8165677Feb 3, 2009Apr 24, 2012Cardiac Pacemakers, Inc.Method and apparatus of acoustic communication for implantable medical deviceUS8185213Oct 22, 2010May 22, 2012Boston Scientific Scimed, Inc.Delivery of cardiac stimulation devicesUS8204605Feb 4, 2009Jun 19, 2012Cardiac Pacemakers, Inc.Multi-site atrial electrostimulationUS8290600 *Jul 21, 2006Oct 16, 2012Boston Scientific Scimed, Inc.Electrical stimulation of body tissue using interconnected electrode assembliesUS8308794Nov 13, 2012IZEK Technologies, Inc.Instrumented implantable stents, vascular grafts and other medical devicesUS8315701 *Nov 20, 2012Ebr Systems, Inc.Leadless tissue stimulation systems and methodsUS8340776 *Dec 25, 2012Cardiac Pacemakers, Inc.Biased acoustic switch for implantable medical deviceUS8340780May 7, 2007Dec 25, 2012Scimed Life Systems, Inc.Leadless cardiac stimulation systemsUS8364276Jan 29, 2013Ebr Systems, Inc.Operation and estimation of output voltage of wireless stimulatorsUS8401665Mar 19, 2013Boston Scientific Neuromodulation CorporationApparatus and methods for detecting position and migration of neurostimulation leadsUS8457757Nov 26, 2008Jun 4, 2013Micro Transponder, Inc.Implantable transponder systems and methodsUS8478408Mar 8, 2007Jul 2, 2013Boston Scientific Scimed Inc.Leadless cardiac stimulation systemsUS8489185Jun 16, 2009Jul 16, 2013The Board Of Regents, The University Of Texas SystemTiming control for paired plasticityUS8491572Jul 27, 2006Jul 23, 2013Izex Technologies, Inc.Instrumented orthopedic and other medical implantsUS8494637 *Jan 18, 2011Jul 23, 2013Ebr Systems, Inc.Systems and methods for implantable leadless gastrointestinal tissue stimulationUS8494639 *Jan 14, 2011Jul 23, 2013Ebr Systems, Inc.Systems and methods for implantable leadless brain stimulationUS8494642 *Jan 14, 2011Jul 23, 2013Ebr Systems, Inc.Systems and methods for implantable leadless spine stimulationUS8494643 *Jan 18, 2011Jul 23, 2013Ebr Systems, Inc.Systems and methods for implantable leadless nerve stimulationUS8494644 *Nov 9, 2011Jul 23, 2013Ebr Systems, Inc.Systems and methods for implantable leadless bone stimulationUS8498715 *Jan 18, 2011Jul 30, 2013Ebr Systems, Inc.Systems and methods for implantable leadless cochlear stimulationUS8577460Mar 11, 2011Nov 5, 2013Remon Medical Technologies, LtdAcoustically powered implantable stimulating deviceUS8593107Oct 26, 2009Nov 26, 2013Cardiac Pacemakers, Inc.Methods and systems for recharging an implanted device by delivering a section of a charging device adjacent the implanted device within a bodyUS8626312Mar 22, 2011Jan 7, 2014Boston Scientific Neuromodulation CorporationNeural stimulation system providing auto adjustment of stimulus output as a function of sensed impedanceUS8634908 *Jul 28, 2006Jan 21, 2014Ebr Systems, Inc.Efficiently delivering acoustic stimulation energy to tissueUS8649875 *Apr 17, 2012Feb 11, 2014Artann Laboratories Inc.Systems for remote generation of electrical signal in tissue based on time-reversal acousticsUS8649876 *Jan 14, 2013Feb 11, 2014Artann Laboratories Inc.Leadless system for deep brain stimulation using time reversal acousticsUS8678979Mar 6, 2007Mar 25, 2014Izex Technologies, Inc.Remote monitoring of a patientUS8682447Jan 30, 2006Mar 25, 2014Boston Scientific Neuromodulation CorporationApparatus and method for determining the relative position and orientation of neurostimulation leadsUS8718757Feb 6, 2012May 6, 2014Boston Scientific Neuromodulation CorporationApparatus and methods for detecting migration of neurostimulation leadsUS8718773 *May 23, 2007May 6, 2014Ebr Systems, Inc.Optimizing energy transmission in a leadless tissue stimulation systemUS8738146Apr 15, 2011May 27, 2014Inria Institut National De Recherche En Informatique Et En AutomatiqueControl device for selective activation of electrode configurationUS8738147Jan 29, 2009May 27, 2014Cardiac Pacemakers, Inc.Wireless tissue electrostimulationUS8740879Sep 12, 2012Jun 3, 2014Izex Technologies, Inc.Instrumented orthopedic and other medical implantsUS8784475Jun 28, 2012Jul 22, 2014Izex Technologies, Inc.Instrumented implantable stents, vascular grafts and other medical devicesUS8788056Aug 16, 2013Jul 22, 2014Boston Scientific Neuromodulation CorporationNeural stimulation system providing auto adjustment of stimulus output as a function of sensed impedanceUS8790258Jan 19, 2010Jul 29, 2014Izex Technologies, Inc.Remote psychological evaluationUS8798761Apr 21, 2009Aug 5, 2014Cardiac Pacemakers, Inc.Systems and methods of monitoring the acoustic coupling of medical devicesUS8934967Jun 16, 2009Jan 13, 2015The Board Of Regents, The University Of Texas SystemSystems, methods and devices for treating tinnitusUS8934972Mar 15, 2013Jan 13, 2015Remon Medical Technologies, Ltd.Acoustically powered implantable stimulating deviceUS8972023Mar 4, 2013Mar 3, 2015Boston Scientific Neuromodulation CorporationApparatus and methods for detecting position and migration of neurostimulation leadsUS8974366Sep 2, 2014Mar 10, 2015Piezo Energy Technologies, LLCHigh power ultrasound wireless transcutaneous energy transfer (US-TET) sourceUS9001622May 22, 2012Apr 7, 2015uBeam Inc.Receiver communications for wireless power transferUS9008776 *Oct 22, 2012Apr 14, 2015Ebr Systems, Inc.Leadless tissue stimulation systems and methodsUS9014803 *Dec 20, 2013Apr 21, 2015Ebr Systems, Inc.Efficiently delivering acoustic stimulation energy to tissueUS9024582Nov 24, 2013May 5, 2015Cardiac Pacemakers, Inc.Methods and systems for recharging an implanted device by delivering a section of a charging device adjacent the implanted device within a bodyUS9067075Mar 28, 2014Jun 30, 2015Boston Scientific Neuromodulation CorporationApparatus and methods for detecting migration of neurostimulation leadsUS9072911Jun 27, 2013Jul 7, 2015Boston Scientific Scimed, Inc.Leadless cardiac stimulation systemsUS9089706Jun 16, 2014Jul 28, 2015Boston Scientific Neuromodulation CorporationNeural stimulation system providing auto adjustment of stimulus output as a function of sensed impedanceUS9089707Jun 15, 2009Jul 28, 2015The Board Of Regents, The University Of Texas SystemSystems, methods and devices for paired plasticityUS9094110May 22, 2012Jul 28, 2015uBeam Inc.Sender transducer for wireless power transferUS9094111May 22, 2012Jul 28, 2015uBeam Inc.Receiver transducer for wireless power transferUS9094112 *May 22, 2012Jul 28, 2015uBeam Inc.Sender controller for wireless power transferUS9180285Oct 21, 2013Nov 10, 2015Ebr Systems, Inc.Implantable wireless accoustic stimulators with high energy conversion efficienciesUS9192760Aug 16, 2010Nov 24, 2015Boston Scientific Neuromodulation CorporationApparatus and method for determining the relative position and orientation of neurostimulation leadsUS9205263May 19, 2010Dec 8, 2015Boston Scientific Neuromodulation CorporationNeural stimulation system providing auto adjustment of stimulus output as a function of sensed impedanceUS9214151 *May 22, 2012Dec 15, 2015uBeam Inc.Receiver controller for wireless power transferUS9230057Feb 13, 2014Jan 5, 2016Izex Technologies, Inc.Remote monitoring of a patientUS9242272Mar 15, 2013Jan 26, 2016uBeam Inc.Ultrasonic driverUS9272145Jul 15, 2013Mar 1, 2016Microtransponder, Inc.Timing control for paired plasticityUS9278375Mar 15, 2013Mar 8, 2016uBeam Inc.Ultrasonic transducer controlUS9308374May 21, 2012Apr 12, 2016Boston Scientific Scimed, Inc.Delivery of cardiac stimulation devicesUS9333364 *Jul 1, 2010May 10, 2016Ebr Systems, Inc.Methods and systems for heart failure treatments using ultrasound and leadless implantable devicesUS9339654Sep 29, 2014May 17, 2016Microtransponder, Inc.Timing control for paired plasticityUS9343654Oct 15, 2015May 17, 2016Ebr Systems, Inc.Method of manufacturing implantable wireless acoustic stimulators with high energy conversion efficienciesUS9345886Sep 26, 2014May 24, 2016Microtransponder, Inc.Timing control for paired plasticityUS20030153959 *Feb 11, 2003Aug 14, 2003Thacker James R.Neural stimulation system providing auto adjustment of stimulus output as a function of sensed coupling efficiencyUS20050187594 *Feb 20, 2004Aug 25, 2005Hatlestad John D.System and method for transmitting energy to and establishing a communications network with one or more implanted devicesUS20060009818 *Jul 9, 2004Jan 12, 2006Von Arx Jeffrey AMethod and apparatus of acoustic communication for implantable medical deviceUS20060074453 *Oct 4, 2004Apr 6, 2006Cvrx, Inc.Baroreflex activation and cardiac resychronization for heart failure treatmentUS20060122653 *Jan 30, 2006Jun 8, 2006Kerry BradleyApparatus and method for determining the relative position and orientation of neurostimulation leadsUS20060122654 *Jan 30, 2006Jun 8, 2006Kerry BradleyApparatus and method for determining the relative position and orientation of neurostimulation leadsUS20060136004 *Dec 21, 2005Jun 22, 2006Ebr Systems, Inc.Leadless tissue stimulation systems and methodsUS20060136005 *Dec 21, 2005Jun 22, 2006Ebr Systems, Inc.Implantable transducer devicesUS20060199620 *Feb 16, 2006Sep 7, 2006Firefly Power Technologies, Inc.Method, apparatus and system for power transmissionUS20060206158 *Mar 9, 2005Sep 14, 2006Wu Eugene YImplantable vagal stimulator for treating cardiac ischemiaUS20060224187 *Apr 1, 2005Oct 5, 2006Kerry BradleyApparatus and methods for detecting position and migration of neurostimulation leadsUS20060224222 *Apr 1, 2005Oct 5, 2006Kerry BradleyApparatus and methods for detecting migration of neurostimulation leadsUS20070027508 *Jul 28, 2006Feb 1, 2007Ebr Systems, Inc.Efficiently delivering acoustic stimulation energy to tissueUS20070060961 *Feb 10, 2006Mar 15, 2007Ebr Systems, Inc.Methods and apparatus for determining cardiac stimulation sites using hemodynamic dataUS20070078490 *Sep 27, 2006Apr 5, 2007Ebr Systems, Inc.Leadless tissue stimulation systems and methodsUS20070149162 *Jan 10, 2007Jun 28, 2007Powercast, LlcPulse transmission methodUS20070249950 *Apr 20, 2006Oct 25, 2007Thomas PiagetImplanted air passage sensorsUS20070293895 *Jun 18, 2007Dec 20, 2007Ebr Systems, Inc.Acoustically-powered wireless defibrillatorUS20070293905 *Jun 18, 2007Dec 20, 2007Ebr Systems, Inc.Systems and methods for implantable leadless gastrointestinal tissue stimulationUS20070293906 *Jun 18, 2007Dec 20, 2007Ebr Systems, Inc.Systems and methods for implantable leadless nerve stimulationUS20070293908 *Jun 18, 2007Dec 20, 2007Ebr Systems, Inc.Systems and methods for implantable leadless brain stimulationUS20070293909 *Jun 18, 2007Dec 20, 2007Ebr Systems, Inc.Systems and methods for implantable leadless spine stimulationUS20070293912 *Jun 18, 2007Dec 20, 2007Ebr Systems, Inc.Systems and methods for implantable leadless bone stimulationUS20070293913 *Jun 18, 2007Dec 20, 2007Ebr Systems, Inc.Systems and methods for implantable leadless cochlear stimulationUS20080103553 *Oct 22, 2007May 1, 2008Remon Medical Technologies Ltd.Systems and methods for communicating with implantable devicesUS20080108915 *Oct 11, 2007May 8, 2008Remon Medical Technologies Ltd.Acoustically powered implantable stimulating deviceUS20080109054 *May 7, 2007May 8, 2008Scimed Life Systems, Inc.Leadless Cardiac Stimulation SystemsUS20080167693 *Oct 5, 2007Jul 10, 2008Cvrx, Inc.Method and apparatus for synchronizing neural stimulation to cardiac cyclesUS20080294208 *May 23, 2007Nov 27, 2008Ebr Systems, Inc.Optimizing energy transmission in a leadless tissue stimulation systemUS20090036940 *Aug 3, 2007Feb 5, 2009Cardiac Pacemakers, IncHypertension diagnosis and therapy using pressure sensorUS20090138275 *Nov 24, 2008May 28, 2009Benjamin MaytalSystem for product authentication powered by phone transmissionUS20090157142 *Nov 26, 2008Jun 18, 2009Microtransponder Inc.Implanted Driver with Charge BalancingUS20090172640 *Dec 26, 2007Jul 2, 2009Medtronic Minimed, Inc.Medical Device With Full Options and Selective Enablement/DisablementUS20090281396 *Nov 12, 2009Wangcai LiaoSystem and Method for Detection of Pulmonary EmbolismUS20090326601 *Dec 31, 2009Ebr Systems, Inc.Implantable transducer devicesUS20100063562 *Sep 4, 2009Mar 11, 2010Ebr Systems, Inc.Leadless tissue stimulation systems and methodsUS20100228308 *Sep 9, 2010Ebr Systems, Inc.Leadless tissue stimulation systems and methodsUS20100234924 *Mar 10, 2010Sep 16, 2010Ebr Systems, Inc.Operation and estimation of output voltage of wireless stimulatorsUS20100262209 *May 19, 2010Oct 14, 2010Boston Scientific Neuromodulation CorporationNeural stimulation system providing auto adjustment of stimulus output as a function of sensed impedanceUS20100286744 *Jul 1, 2010Nov 11, 2010Ebr Systems, Inc.Methods and systems for heart failure treatments using ultrasound and leadless implantable devicesUS20100305631 *Dec 2, 2010Boston Scientific Neuromodulation CorporationApparatus and method for determining the relative position and orientation of neurostimulation leadsUS20110034826 *Apr 7, 2009Feb 10, 2011Notz JuergenSurgical apparatus comprising a nerve testing deviceUS20110060387 *Nov 15, 2010Mar 10, 2011Boston Scientific Neuromodulation CorporationNeural stimulation system providing auto adjustment of stimulus output as a function of sensed impedanceUS20110112600 *May 12, 2011Ebr Systems, Inc.Systems and methods for implantable leadless gastrointestinal tissue stimulationUS20110118810 *May 19, 2011Ebr Systems, Inc.Systems and methods for implantable leadless nerve stimulationUS20110144720 *Jun 16, 2011Ebr Systems, Inc.Systems and methods for implantable leadless cochlear stimulationUS20110166620 *Jul 7, 2011Ebr Systems, Inc.Systems and methods for implantable leadless brain stimulationUS20110166621 *Jul 7, 2011Ebr Systems, Inc.Systems and methods for implantable leadless spine stimulationUS20110190847 *Aug 4, 2011Boston Scientific Neuromodulation CorporationNeural stimulation system providing auto adjustment of stimulus output as a function of sensed impedanceUS20110270366 *Mar 9, 2011Nov 3, 2011Cameron MahonRF power controller for ultrasound therapy systemUS20120059433 *Nov 9, 2011Mar 8, 2012Ebr Systems, Inc.Systems and methods for implantable leadless bone stimulationUS20120100805 *Jul 12, 2010Apr 26, 2012Davide FabianiDevice and method for transmitting a signal through a body made of dielectric materialUS20120203306 *Apr 17, 2012Aug 9, 2012Artann Laboratories, Inc.Systems for remote generation of electrical signal in tissue based on time-reversal acousticsUS20120299540 *May 22, 2012Nov 29, 2012uBeam Inc.Sender communications for wireless power transferUS20120299541 *May 22, 2012Nov 29, 2012uBeam Inc.Sender controller for wireless power transferUS20120299542 *Nov 29, 2012uBeam Inc.Receiver controller for wireless power transferUS20130018440 *Mar 29, 2012Jan 17, 2013Cyberonics, Inc.Powering of an implantable medical therapy delivery device using far field radiative powering at multiple frequenciesUS20130131754 *May 23, 2013Armen P. SarvazyanLeadless system for deep brain stimulation using time reversal acousticsUS20130261703 *Apr 24, 2013Oct 3, 2013Cyberonics, Inc.Powering multiple implantable medical therapy delivery devices using far field radiative powering at multiple frequenciesUS20130282070 *Jun 20, 2013Oct 24, 2013Ebr Systems, Inc.Systems and methods for implantable leadless tissue stimulationUS20130282073 *Oct 22, 2012Oct 24, 2013Ebr Systems, Inc.Leadless tissue stimulation systems and methodsUS20140028467 *Sep 30, 2013Jan 30, 2014Endotronix, Inc.Wireless sensor readerUS20140087451 *Aug 20, 2013Mar 27, 2014University Of MassachusettsAcoustic wave (aw) sensing devices using live cellsUS20140107725 *Dec 20, 2013Apr 17, 2014Ebr Systems, Inc.Efficiently delivering acoustic stimulation energy to tissueUSRE42378May 17, 2011Remon Medical Technologies, Ltd.Implantable pressure sensors and methods for making and using themCN102971043A *Apr 15, 2011Mar 13, 2013国家信息及自动化研究院Control device for selective activation of electrode configurationEP1915192A2 *Jul 31, 2006Apr 30, 2008EBR Systems, Inc.Efficiently delivering acoustic stimulation energy to tissueEP2544761A1 *Mar 10, 2011Jan 16, 2013EBR Systems, Inc.Operation and estimation of output voltage of wireless stimulatorsEP2544761A4 *Mar 10, 2011Oct 30, 2013Ebr Systems IncOperation and estimation of output voltage of wireless stimulatorsWO2006041664A2 *Sep 23, 2005Apr 20, 2006Cvrx, Inc.Baroreflex activation and cardiac resynchronization for heart failure treatmentWO2006055547A2 *Nov 15, 2005May 26, 2006Izex Technologies, Inc.Instrumented orthopedic and other medical implantsWO2006069215A3 *Dec 21, 2005Jun 18, 2009Ebr Systems IncLeadless cardiac system for pacing and arrhythmia treatmentWO2007016581A2Jul 31, 2006Feb 8, 2007Ebr Systems, Inc.Efficiently delivering acoustic stimulation energy to tissueWO2007081971A2 *Jan 10, 2007Jul 19, 2007Powercast CorporationPulse transmission methodWO2007149931A2 *Jun 20, 2007Dec 27, 2007Ebr Systems, Inc.Acoustically-powered wireless defibrillatorWO2007149936A2 *Jun 20, 2007Dec 27, 2007Ebr Systems, Inc.Systems and methods for implantable leadless tissue stimulationWO2008111998A1 *Jul 23, 2007Sep 18, 2008Boston Scientific Scimed, Inc.Electrical stimulation of body tissue using interconnected electrode assembliesWO2008118908A1 *Mar 25, 2008Oct 2, 2008Remon Medical Technologies, Ltd.Biased acoustic switch for implantable medical deviceWO2009070697A2 *Nov 26, 2008Jun 4, 2009Micro Transponder Inc.Implantable transponder systems and methodsWO2009082553A1 *Nov 10, 2008Jul 2, 2009Medtronic Minimed, Inc.Medical device with full options and selective enablement/disablementWO2009120785A2Mar 25, 2009Oct 1, 2009Ebr Systems, Inc.Implantable wireless acoustic stimulators with high energy conversion efficienciesWO2009137189A1 *Mar 30, 2009Nov 12, 2009Cardiac Pacemakers, Inc.System and method for detection of pulmonary embolismWO2011112865A1Mar 10, 2011Sep 15, 2011Ebr Systems, IncOperation and estimation of output voltage of wireless stimulatorsWO2011128601A1 *Apr 15, 2011Oct 20, 2011Inria Institut National De Recherche En Informatique Et En AutomatiqueControl device for selective activation of electrode configuration* Cited by examinerClassifications U.S. Classification607/35International ClassificationA61B5/00, A61N1/372, A61B17/00, A61N1/08, A61N1/378Cooperative ClassificationA61N1/362, A61N1/37217, A61B2562/028, A61B2560/0219, A61B5/0031, A61B2017/00026, A61N1/3787, A61N7/00, A61N1/3718, A61N1/08European ClassificationA61B5/00B9, A61N1/08, A61N1/378CLegal EventsDateCodeEventDescriptionMay 12, 2004ASAssignmentOwner name: REMON MEDICAL TECHNOLOGIES LTD., ISRAELFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PENNER, AVI;REEL/FRAME:014622/0712Effective date: 20040502Mar 17, 2011FPAYFee paymentYear of fee payment: 4Apr 1, 2015FPAYFee paymentYear of fee payment: 8RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services